MYRIAD GENETICS INC — Director's Dealing 2020

Sep 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-09-24

Reporting Person: Riggsbee Richard Bryan (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-24	Common Stock	A	41000	$0.0	Acquired	296491	Direct
2020-09-25	Common Stock	D	5267	$12.44	Disposed	291224	Direct
2020-09-25	Common Stock	D	6653	$12.44	Disposed	284571	Direct
2020-09-26	Common Stock	D	4546	$12.44	Disposed	280025	Direct

Footnotes

F1: Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan. Performance stock units initially granted on September 25, 2019, subject to accomplishment of pre-determined financial performance requirements. On September 24, 2020, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements. Each performance stock unit represents a contingent right to receive one share of the Companys common stock, and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023.

F2: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person.